Genomic Technology Applied to Pharmacological Traits
Year: 2011
Type: article
Abstract: Advances in genomic technologies have enabled a deeper understanding of a variety of phenotypes relevant to clinical medicine. The ability to test hundreds of thousands of inherited genetic markers for association with medical traits (genome-wide association studies, or GWAS) has led to exciting new discoveries. While GWAS of diseases focuses on disease onset and rate of progression, the term pharmacogenomics refers to the application of GWAS and related genomic technologies to understanding variability in treatment outcome of a disease (a drug's efficacy or toxicity).
Source: JAMA
Authors: Jun J. Yang, Robert M. Plenge
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Awards: PAAR4Kids-Pharmacogenomics of Anticancer Agents Research in Children, Deep Re-Sequencing of Rheumatoid Arthritis Risk Loci, Dissection of two rheumatoid arthritis risk loci from genome-wide studies, Meta-analysis of GWAS data to identify novel rheumatoid arthritis risk loci, PDE4B and pharmacoethnicity of childhood leukemia, Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis, Pharmacogenomics of Racial Disparities in Childhood Leukemia Outcomes
OpenAlex ID: W2002739814
